{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-007238","form_type":"8-K","ticker":"CNSP","cik":"0001729427","company_name":"CNS Pharmaceuticals, Inc.","filed_at":"2023-10-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.210748+00:00","generated_at":"2026-06-09T21:53:13.345280+00:00","sec_items":["7.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"CNS Pharmaceuticals posts investor video on Berubicin trial","bullets":["CEO John Climaco discusses Berubicin clinical trial in Virtual Investor event.","Event link posted on October 18, 2023; no financial data or trial results disclosed in 8-K.","No specific quantitative updates or forward guidance provided in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-007238","json":"https://secwatch.observer/filing/0001683168-23-007238.json","markdown":"https://secwatch.observer/filing/0001683168-23-007238.md","text":"https://secwatch.observer/filing/0001683168-23-007238.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1729427/000168316823007238/0001683168-23-007238-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1729427/000168316823007238/cns_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T21:53:13.345280+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}